DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 12 filers reported holding DIAMEDICA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $640,000 | – | 219,973 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,197,245 | $2,993,000 | 1.24% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 265,000 | $663,000 | 0.40% |
COOPERMAN LEON G | 812,508 | $2,031,270 | 0.11% |
Ikarian Capital, LLC | 221,252 | $553,000 | 0.07% |
Shay Capital LLC | 10,000 | $25,000 | 0.00% |
Sandy Cove Advisors, LLC | 1,200 | $3,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 20,603 | $52,000 | 0.00% |
Newbridge Financial Services Group, Inc. | 1,269 | $3,000 | 0.00% |
Patriot Financial Group Insurance Agency, LLC | 1,300 | $3,000 | 0.00% |
GROUP ONE TRADING, L.P. | 20 | $0 | 0.00% |